parsisotope
Order registration
| Contact Us |

Follow Us:

LinkedIn
Instagram
Telegram
YouTube
mail

info@Parsisotope.com

phone

+98-2142180000

location_on

No.88, West 23rd St.Azadegan Blvd. South Sheykh Bahaie Ave. Tehran, Iran

language
PersianSpanishArabic

PARS‑UBI® Kit

 Sterile, NonPyrogen Lyophilized Powder

done
SPECT Imaging
done
Diagnostic
circle
About the Product

PARS‑UBI is a sterile, non‑pyrogen lyophilized radiopharmaceutical kit for the preparation of 99mTc‑UBI, used for the diagnosis of infections. Each vial contains 50 µg of lyophilized HYNIC‑Ubiquicidin, which, after radiolabeling with Tc‑99m, is administered intravenously and is intended solely for diagnostic use. The resulting radiopharmaceutical, through selective binding to bacteria, helps differentiate bacterial infections from sterile inflammation in SPECT imaging.

circle
Applications
  • Diagnosis of acute and chronic bacterial infections
  • Differentiation of bacterial infection from sterile inflammation
  • Precise localization of the infection focus in the body
  • Assistance in therapeutic decision‑making and monitoring response to infection treatment
circle
Mechanism of Action

HYNIC‑Ubiquicidin (UBI) is a synthetic peptide with a positive charge (cationic) that exhibits specific affinity for binding to the negatively charged cell wall of bacteria in infectious areas. This property allows it to be used for identifying the site of infection. After injection, 99mTc‑UBI binds to infectious foci in the body and accumulates at sites where bacteria are present, enabling detection and imaging of microbial infections.

circle
Preparation and Administration

Note: This pharmaceutical product is intended solely for use in nuclear medicine facilities by personnel experienced in handling radiopharmaceuticals.

The PARS‑UBI® kit is radiolabeled with a specified amount of sterile, non‑pyrogen sodium pertechnetate injection (Na99mTcO₄), eluted from a 99Mo/99mTc generator, at the prescribed activity, and is then prepared for intravenous administration as a single dose.

circle
Box Contents

Each box contains one instruction leaflet and one UBI kit vial, along with one label specifically for the radiolabeling procedure.

circle
Composition

HYNIC Ubiquicidin (50 µg)

Stannous Chloride Dihydrate

Tricine

Sodium Acetate

Mannitol

circle
Storage Conditions
  • Store the PARS‑UBI® kit in a freezer (-8°C to -20°C) and protected from light. The cold chain must be maintained under all circumstances.
  • After radiolabeling, 99mTc‑UBI remains stable for up to 4 hours at 15°C to 25°
  • The PARS‑UBI® kit should not be used after the expiration date.
You must be logged in to post a comment.
Menu